Cite

HARVARD Citation

    Anastasiou, P. et al. (n.d.). Combination of KRASG12C(ON) and SHP2 inhibitors overcomes adaptive resistance and enhances anti-tumour immunity. European journal of cancer. pp. S62-. [Online]. 
  
Back to record